Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
319.50    2.00 (0.63%)
Bid:
320.00
Ask:
320.50
Spread: 0.50 (0.156%)
Market Cap: £736.98m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

PDMR and Total Voting Rights

21 May 2018 17:16

RNS Number : 7861O
Chesnara PLC
21 May 2018
 

 

 

 

CHESNARA plc

("Chesnara" or "the Company")

 

Notification of PDMR Dealing and Total Voting Rights

 

Chesnara plc (the 'Company') today announces that the following PDMR has exercised options over ordinary shares as a result of the vesting of the awards made on 28 May 2014 under the 2014 Chesnara Long Term Incentive scheme ('LTI') and Short Term Incentive Scheme ("STI"). Of these, 29,168 shares were sold to cover liability to tax and national insurance contributions arising on vesting, with the balance being retained.

 

In conformity with 5.6.1 of the FCA Disclosure and Transparency Rules (the "Rules"), the Company notifies the market that, as at the date of this announcement, its issued capital comprised 149,885,761 ordinary 5p shares including 24,980 held in treasury.

The total number of voting rights is therefore 149,860,781 (being the Company's issued share capital less the number of shares held in treasury).

Shareholders should therefore use 149,860,781 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Rules.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Rimmington

2

Reason for the notification

a)

Position/status

Chief Finance Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chesnara plc

b)

LEI

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Chesnara plc Ordinary shares of 5 pence each (Shares)

ID Code: (GB00B00FPT80)

b)

Nature of the transaction

 

1. Exercise of options over 38,635 shares following vesting of the conditional awards under the 2014 Long Term Incentive scheme.

2. Exercise of options over 14,086 shares following vesting of the conditional awards under the 2014 Short Term Incentive scheme.

3. 29,168 shares sold to cover tax and social security obligations

c)

Price(s) and volume(s)

1 & 2 Price(s): nil. Volume: 52,721.

3 Price): 392.6p. Volume: 29,168.

d)

Aggregated information

N/A

e)

Date of the transaction

16 May 2018

f)

Place of the transaction

1 & 2 - XOFF

3 - London Stock Exchange (XLON)

 

The above notification is made in accordance with the requirements of the EU Market Abuse Regulation.

Notes to Editors

Chesnara plc ('Chesnara'), which listed on the London Stock Exchange in May 2004, is the owner of Countrywide Assured plc ('CA plc'), Movestic Livförsäkringar AB ('Movestic') and Chesnara Holdings BV. Chesnara Holdings BV is the intermediate holding company of 'Waard Group' and 'Scildon'.

 

CA plc is a UK life assurance subsidiary that is closed to new business. In June 2005 Chesnara acquired a further closed life insurance company - City of Westminster Assurance - for £47.8m. With effect from 30 June 2006, CWA's policies and assets were transferred into CA plc. Save & Prosper Insurance Limited and its subsidiary, Save & Prosper Pensions Limited, were acquired on 20 December 2010 for £63.5 million. With effect from 31 December 2011, the business of Save & Prosper was transferred into CA plc. On 28 November 2013 Chesnara acquired Direct Line Life Insurance Company Limited (subsequently renamed Protection Life Company Limited) from Direct Line Group plc for £39.3m. On 31 December 2014 the PL business transferred into CA plc. CA plc operates an outsourced business model.

 

Movestic, a Swedish life assurance company which originally focused on pensions and savings, was acquired on 23 July 2009 for £20 million. The company is open to new business and seeks to grow its position in the Swedish unit-linked market. Its proposition was strengthened in February 2010 with the acquisition of the operations of Aspis Försäkringar Liv AB which has a risk and health product bias.

 

The Waard Group, a Netherlands-based Group comprising three closed book insurance companies and a servicing company, was acquired on 19 May 2015 for €69.9m. The Waard Group, comprising Waard Leven N.V., Hollands Welvaren Leven N.V., Waard Schade N.V. and Tadas Verzekeringen B.V. was previously owned by DSB Beheer B.V., a Dutch financial services Group. The policy base of the Waard Group is predominantly term life policies, with some unit linked policies and some non-life policies. On 5 April 2017 Chesnara completed its acquisition of Legal & General Nederland Levensverzeikering Maatschappij N.V. ('LGN') for €161.2 million. The LGN business which has been renamed Scildon, is in the Dutch life assurance market, and as with our Swedish subsidiary Movestic, Scildon writes protection and pension new business. 

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRABMFTMBBTBIP
Date   Source Headline
13th May 20251:00 pmRNSSenior Independent Director Appointment
13th May 202512:44 pmRNSAGM Statement
1st May 20257:00 amRNSTotal Voting Rights
25th Apr 20257:00 amRNSBlock listing Interim Review
24th Apr 20257:00 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSNotice of AGM
7th Apr 202512:30 pmRNSApplication for Block Listing - Replacement
7th Apr 202512:09 pmRNSDirector/PDMR Shareholding
4th Apr 202512:00 pmRNSApplication for Block Listing
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20252:45 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
10th Mar 20251:41 pmRNSNotice of Results (Replacement)
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20259:07 amRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSDirectorate Changes
23rd Dec 20247:00 amRNSAcquisition
12th Dec 202412:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20241:55 pmRNSDirector/PDMR Shareholding
14th Nov 20242:06 pmRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20247:00 amRNSBlock listing Interim Review
11th Sep 20247:00 amRNSDirector/PDMR Shareholding
10th Sep 20247:00 amRNSHalf-year Report
12th Aug 20249:00 amRNSNotice of Half Year Results
1st Aug 20247:00 amRNSDirector/PDMR Shareholding
18th Jul 20249:00 amRNSExternal Directorship
10th Jul 20249:00 amRNSHolding(s) in Company
7th Jun 202411:28 amRNSDirector/PDMR Shareholding
6th Jun 20243:30 pmEQSHardman Talks Video | Chesnara plc (CSN) Management Presentation and Q&A
16th May 20247:00 amRNSDirector/PDMR Shareholding
14th May 20242:15 pmRNSAGM Statement
9th May 20242:04 pmEQSQ&A on Chesnara plc (CSN): Growth and stability insights
30th Apr 20244:45 pmRNSDirector/PDMR Shareholding
26th Apr 20244:57 pmRNSDirector/PDMR Shareholding
25th Apr 202410:00 amRNSBlock listing Interim Review
17th Apr 202410:00 amRNSNotice of AGM
16th Apr 20241:00 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSDirectorate Change
11th Apr 202410:23 amEQSHardman & Co Research on Chesnara plc (CSN): Good 2023 results set platform for future progress
9th Apr 20244:58 pmRNSDirectorate Change
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
3rd Apr 20241:33 pmRNSDirector/PDMR Shareholding
28th Mar 202412:00 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSFinal Results
21st Mar 20247:45 amRNSDirector Declaration
14th Mar 202411:15 amRNSNotice of Results
29th Dec 202311:55 amRNSTotal Voting Rights
29th Dec 202311:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.